Dr. Sausville is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
22 S Greene St
Baltimore, MD 21201Phone+1 410-328-7394Fax+1 410-328-6896- Is this information wrong?
Education & Training
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1982 - 1985
Brigham and Women's HospitalResidency, Internal Medicine, 1979 - 1982
Albert Einstein College of MedicineClass of 1979
Certifications & Licensure
MD State Medical License 1982 - 2023
DC State Medical License 1988 - 2016
VA State Medical License 1982 - 2004- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Whos Who in Medicine and Healthcare Marquis Whos Who
Clinical Trials
- Monoclonal Antibody Therapy in Treating Patients With Recurrent or Refractory Lymphoma Start of enrollment: 2000 Nov 01
- Flavopiridol in Treating Patients With Refractory Cancer Start of enrollment: 1997 Aug 01
- Perifosine in Treating Patients With Refractory Solid Tumors or Hematologic Cancer Start of enrollment: 1999 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- Phase 1 trial of navitoclax and sorafenib in patients with relapsed or refractory solid tumors with hepatocellular carcinoma expansion cohort.Emiloju, O., Yin, J., Koubek, E., Reid, J., Borad, M., Lou, Y., Seetharam, M., Edelman, M., Sausville, E., Jiang, Y., Kaseb, A., Posey, J., Davis, S., Gores, G., Rober...> ;Investigational New Drugs. 2024 Feb 1
- Replacement of Antiretroviral Therapy with HIV Broadly Neutralizing Antibodies to Maximize the Effectiveness of Chemotherapy in HIV Patients with Lung Cancer.Ben Atkinson, Abdolrahim Abassi, Mohammad M Sajadi, Zahra Rikhtegaran Tehrani, Nhut M Le, Hegang H Chen, Edward Sausville, Anthony L DeVico, George K Lewis, Xiaoxuan F...> ;AIDS Research and Human Retroviruses. 2023 Sep 1
- 5 citationsPeripheral blood blast rate of clearance is an independent predictor of clinical response and outcomes in acute myeloid leukaemia.Noa G. Holtzman, Firas El Chaer, Maria R. Baer, Omer Ali, Ameet Patel, Vu H. Duong, Edward A. Sausville, Zeba N. Singh, Rima Koka, Ying S. Zou, Arash Etemadi, Ashkan E...> ;British Journal of Haematology. 2020 Mar 1
- Join now to see all
Grant Support
- Umgcc PAUL Calabresi Clinical Oncology Training ProgramNational Cancer Institute2008–2011
- Clinical Research Shared ServiceNational Cancer Institute2008–2010
- Clinical Trial: Treatment Of Melanoma With Wild-Type P53 And A 100b Using PentaNational Center For Research Resources2009
- Treatment Of Melanoma With Wild-Type P53 And Detectable S100B Using Pentamidine:National Cancer Institute2008–2009
- Clinical Trial: Phase I Study Of IV 17-AAG And Oral BAY 43-9006 In Patients WithNational Center For Research Resources2008
- 0629gcc: A Phase I, Open-Label, Multi-Center, Dose-Escalation Study To Assess SLNational Center For Research Resources2007
- 0458gcc: A Phase I Dose Escalation Study Of Intravenous 17-AAGNational Center For Research Resources2007
- Phase 1 Of Sorafenib PLUS 17AAG In Solid Tumor PatientsNational Center For Research Resources2006
- Immunotoxin Protocols Under The Medicine Branch: TargeteDivision Of Clinical Sciences - Nci2001
- Protein Kinase Antagonists: Preclinical And ClinicalDivision Of Clinical Sciences - Nci1999–2001
- Immunotoxin Protocols Under The Medicine Branch: Targeted Therapy Of Lymphoid NEDivision Of Clinical Sciences - Nci2000
- Immunotoxin Protocols Under The Medicine Branch: Targeted Therapy Of Lymphoid NEODivision Of Clinical Sciences - Nci1999
Hospital Affiliations
University of Maryland Baltimore Washington Medical CenterGlen Burnie, Maryland
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
